Want to see IN:PGHH full AI Analyst Report?
Top Page
Procter & Gamble Hygiene & Health Care Ltd.
(PGHH)
Select Model
Select Model
Rating:68Neutral
Price Target:
₹8,267.00
▼(-7.78% Downside)
Action:Reiterated
Date:07/01/26
The score is primarily supported by strong financial performance—high profitability, strong cash conversion, and very low balance-sheet risk. Offsetting this, technicals are weak with the stock below major moving averages, and valuation looks demanding (high P/E) despite a supportive dividend yield.
Positive Factors
Branded FMCG portfolio
Established Whisper and Vicks brands give PGHH a recognizable position in recurring hygiene and health-care purchases. Combined with distribution through retail and other trade channels, this supports product availability, repeat demand, and brand-led resilience over the next several quarters.
Negative Factors
Recent revenue contraction
The latest annual revenue decline interrupts earlier expansion and creates uncertainty around the durability of demand and topline growth. Even with margins holding up, continued contraction would restrict operating leverage, reduce reinvestment capacity, and make future earnings growth harder to sustain.
Read all positive and negative factors
Positive Factors
Negative Factors
Branded FMCG portfolio
Established Whisper and Vicks brands give PGHH a recognizable position in recurring hygiene and health-care purchases. Combined with distribution through retail and other trade channels, this supports product availability, repeat demand, and brand-led resilience over the next several quarters.
Read all positive factors
Procter & Gamble Hygiene & Health Care Ltd. (PGHH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹246.19B
Dividend Yield3.9%
Average Volume (3M)2.39K
Price to Earnings (P/E)28.5
Beta (1Y)0.28
Revenue Growth-1.54%
EPS Growth-4.58%
CountryIN
Employees439
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)254.65
Shares Outstanding32,460,735
10 Day Avg. Volume1,300
30 Day Avg. Volume2,386
Financial Highlights & Ratios
PEG Ratio40.59
Price to Book (P/B)42.00
Price to Sales (P/S)7.39
P/FCF Ratio36.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)281.55
Revenue Forecast (FY)₹47.07B
Procter & Gamble Hygiene & Health Care Ltd. Business Overview & Revenue Model
Company Description
Established in 1964 and headquartered in Mumbai, India, Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of Procter & Gamble Overseas India BV. The company specializes in the manufacturing and worldwide distribution of bra...
How the Company Makes Money
PGHH primarily makes money by selling branded consumer products in India, generating revenue from the sale of its hygiene and health care portfolio to distributors, wholesalers, retailers, pharmacies, and other trade customers who then sell to end...
Procter & Gamble Hygiene & Health Care Ltd. Financial Statement Overview
Summary
Income Statement
83
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
88
Very Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.19B | 42.82B | 44.99B | 41.92B | 39.05B | 37.92B |
| Gross Profit | 26.99B | 24.73B | 25.48B | 23.52B | 20.24B | 20.30B |
| EBITDA | 11.78B | 11.71B | 12.11B | 10.23B | 9.09B | 8.54B |
| Net Income | 8.27B | 8.56B | 8.49B | 6.75B | 6.78B | 5.76B |
Balance Sheet | ||||||
| Total Assets | 17.55B | 18.04B | 17.55B | 18.59B | 21.37B | 16.81B |
| Cash, Cash Equivalents and Short-Term Investments | 5.16B | 5.68B | 5.16B | 5.74B | 9.64B | 6.25B |
| Total Debt | 23.20M | 8.70M | 23.20M | 30.80M | 40.30M | 51.00M |
| Total Liabilities | 10.18B | 10.50B | 10.18B | 10.84B | 11.91B | 9.44B |
| Stockholders Equity | 7.37B | 7.53B | 7.37B | 7.75B | 9.46B | 7.38B |
Cash Flow | ||||||
| Free Cash Flow | 6.08B | 8.75B | 5.63B | 4.26B | 7.81B | 5.23B |
| Operating Cash Flow | 6.76B | 9.24B | 6.18B | 4.71B | 8.26B | 5.73B |
| Investing Cash Flow | -586.30M | 113.70M | -586.30M | 10.60M | -99.10M | -268.50M |
| Financing Cash Flow | -6.66B | -8.45B | -6.66B | -8.62B | -4.77B | -5.69B |
Procter & Gamble Hygiene & Health Care Ltd. Technical Analysis
Negative
8963.95
Price Trends
8365.64
Negative
8915.66
Negative
10173.94
Negative
Market Momentum
-236.03
Positive
19.87
Positive
3.16
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PGHH, the sentiment is Negative. The current price of 8963.95 is above the 20-day moving average (MA) of 7918.21, above the 50-day MA of 8365.64, and below the 200-day MA of 10173.94, indicating a bearish trend. The MACD of -236.03 indicates Positive momentum. The RSI at 19.87 is Positive, neither overbought nor oversold. The STOCH value of 3.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PGHH.
Procter & Gamble Hygiene & Health Care Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ₹1.04T | 55.01 | ― | 0.50% | 25.00% | 12.83% | |
69 Neutral | ₹4.55T | 30.27 | ― | 2.12% | 3.83% | 38.55% | |
68 Neutral | ₹246.19B | 28.49 | ― | 3.90% | -1.54% | -4.58% | |
67 Neutral | ₹492.29B | 36.27 | ― | 2.67% | 3.79% | -3.28% | |
65 Neutral | ₹669.67B | 33.81 | ― | 2.19% | 7.40% | 10.63% | |
59 Neutral | ₹891.30B | 46.23 | ― | 2.30% | 9.22% | 3.19% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:PGHH
Procter & Gamble Hygiene & Health Care Ltd.
7,519.40
-5,371.55
-41.67%
IN:COLPAL
Colgate-Palmolive (India) Limited
1,797.60
-503.46
-21.88%
IN:DABUR
Dabur India Limited
376.50
-152.61
-28.84%
IN:GODREJCP
Godrej Consumer Products Limited
864.60
-360.39
-29.42%
IN:HINDUNILVR
Hindustan Unilever Limited
1,934.00
-561.13
-22.49%
IN:MARICO
Marico Limited
804.00
72.75
9.95%
Procter & Gamble Hygiene & Health Care Ltd. Corporate Events
P&G Hygiene Resets Dividend Record Date Ahead of September AGM
Aug 7, 2026
Procter Gamble Hygiene and Health Care Limited has revised the record date for determining shareholders eligible for dividend and participation at its 62nd Annual General Meeting to 1 September 2026. The AGM will be held on 8 September 2026, and,...
P&G Hygiene Sets AGM and Dividend Timeline for September 2026
Aug 7, 2026
Procter Gamble Hygiene and Health Care Ltd. has scheduled its 62nd Annual General Meeting for September 8, 2026, as disclosed to both BSE and the National Stock Exchange. The company has set September 1, 2026 as the record date for determining sh...
P&G Hygiene and Health Care names new Sales Head as leadership shifts to Korea role
Jul 1, 2026
Procter Gamble Hygiene and Health Care Ltd. announced a leadership transition in its sales function, with seasoned executive Gopalakrishnan Kalianna set to become Sales Head effective August 1, 2026. Kalianna brings over two decades of experience...
P&G Hygiene & Health Care shuts trading window ahead of Q1 FY27 results
Jun 26, 2026
Procter Gamble Hygiene Health Care Ltd. has notified stock exchanges that its trading window will be closed for directors and designated employees from July 1, 2026, until 48 hours after the publication of its unaudited financial results for the...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.